Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment Plans
Year: 2025
Type: review
Language: en
Topic: Migraine and Headache Studies
Authors and affiliations:
raw_author_name: Peter J. Goadsby
raw_affiliation_strings: Headache Group, NIHR King's Clinical Research Facility and SLaM Biomedical Research Centre, The Wolfson Sensory, Pain and Regeneration Research Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, King's College Hospital, Wellcome Foundation Building, London, SE5 9PJ, UK. peter.goadsby@kcl.ac.uk
King Abdullah University of Science and Technology, Thuwal, Saudi Arabia. peter.goadsby@kcl.ac.uk
King Abdullah University of Science and Technology, Thuwal, Saudi Arabia
Headache Group, NIHR King's Clinical Research Facility and SLaM Biomedical Research Centre, The Wolfson Sensory, Pain and Regeneration Research Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, King's College Hospital, Wellcome Foundation Building, London, SE5 9PJ, UK
raw_author_name: Alexandra J. Sinclair
raw_affiliation_strings: Department of Neurology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
raw_author_name: Shazia K. Afridi
raw_affiliation_strings: Neurology Department, Guy's and St Thomas' NHS Foundation Trust, London, UK
raw_author_name: Christian Lucas
raw_affiliation_strings: Pain Clinic, Service de Neurochirurgie, Hôpital Salengro, CHU de Lille, Lille, France
raw_author_name: Jerôme Mawet
raw_affiliation_strings: Emergency Headache Centre, Department of Neurology, Lariboisiere Hospital, Assistance Publique des Hopitaux de Paris, Paris, France
raw_author_name: Michel Lanteri-Minet
raw_affiliation_strings: Inserm U1107, Neuro-Dol, Trigeminal Pain and Migraine, Université Clermont Auvergne, Clermont-Ferrand, France
Pain Départment, UR2CA-PIN, FHU InovPain, CHU Nice and Université Côte Azur, Nice, France
raw_author_name: Xavier Moisset
raw_affiliation_strings: CHU de Clermont-Ferrand, Inserm, Neuro-Dol, Service de Neurologie, Université Clermont-Auvergne, Clermont-Ferrand, France
raw_author_name: Hans Christoph Diener
raw_affiliation_strings: Department of Neuroepidemiology, Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), Medical Faculty of the University Duisburg-Essen, Essen, Germany
raw_author_name: Charly Gaul
raw_affiliation_strings: Headache Center Frankfurt, Frankfurt a. M., Germany
Medical Faculty, University of Duisburg-Essen, Essen, Germany
raw_author_name: Tim Patrick Jürgens
raw_affiliation_strings: Klinik und Poliklinik für Neurologie, Kopfschmerzzentrum Nord-Ost, Rostock, Germany
Neurologisches Zentrum, Neurologische Klinik, KMG Klinikum Güstrow, Güstrow, Germany
raw_author_name: Marja-Liisa Sumelahti
raw_affiliation_strings: Faculty of Medicine and Health Technology, University of Tampere, Tampere, Finland
raw_author_name: Margarita Sanchez del Rio
raw_affiliation_strings: Department of Neurology, Clínica Universidad de Navarra, Madrid, Spain
raw_author_name: Patricia del Pozo-Rosich
raw_affiliation_strings: Migraine Adaptive Brain Center, Neurology Department, Vall d'Hebron University Hospital and Headache Research Group Vall d'Hebron Institute of Research, Barcelona, Spain
raw_author_name: Antonio Russo
raw_affiliation_strings: Department of Advanced Medical and Surgical Sciences, Headache Centre, University of Campania "Luigi Vanvitelli", Naples, Italy
raw_author_name: Piero Barbanti
raw_affiliation_strings: Headache and Pain Unit, IRCCS San Raffaele, Rome, Italy
San Raffaele University, Rome, Italy